## Abstract **Background** Tuberculosis continues to be a health problem in some countries. The development of resistance to antituberculitic drugs and the increase in diseases and conditions associated with immunodeficiency such as AIDS and chemotherapy have caused tuberculosis to increase recentl
Immunocorrectors in the treatment of patients with lung tuberculosis
β Scribed by A.A. Umnyashkin
- Publisher
- Elsevier Science
- Year
- 1991
- Tongue
- English
- Weight
- 66 KB
- Volume
- 13
- Category
- Article
- ISSN
- 0192-0561
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
D-penicillamine has been used to treat systemic sclerosis (scleroderma) for nearly two decades. Improvement in cutaneous fibrosis in patients treated with this drug has been documented in a number of uncontrolled studies (1). The effect of D-penicillamine on established visceral involvement due to s
## Background: In an attempt to improve treatment results of small cell lung cancer (sclc), combined induction chemotherapy and thoracic and prophylactic brain radiation therapy were administered. ## Method: From december 1980 to december 1987, 112 patients with limited-stage sclc were treated wi